<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: regulatory t cells</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Modulating the immune system to combat metastatic cancer</title>
   	 <description>Cancer cells spread and grow by avoiding detection and destruction by the immune system. Stimulation of the immune system can help to eliminate cancer cells; however, there are many factors that cause the immune system to ignore cancer cells. Regulatory T cells are immune cells that function to suppress the immune system response.</description>
	  <link>http://medicalxpress.com/news/2013-05-modulating-immune-combat-metastatic-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 24 May 2013 12:31:48 EST</pubDate>
	 <guid isPermaLink="false">news288617502</guid>
	 
</item>
<item>
     <title>Thymus teaches immune cells to ignore vital gut bacteria</title>
   	 <description>The tiny thymus teaches the immune system to ignore the teeming, foreign bacteria in the gut that helps you digest and absorb food, researchers say.</description>
	  <link>http://medicalxpress.com/news/2013-04-thymus-immune-cells-vital-gut.html</link>
	 <category>Immunology</category>
	 <pubDate>Mon, 29 Apr 2013 12:04:49 EST</pubDate>
	 <guid isPermaLink="false">news286455882</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/thymusteache.jpg" width="90" height="90" />
</item>
<item>
     <title>Study identifies biomarker and potential therapy target in multiple sclerosis</title>
   	 <description>Researchers from Benaroya Research Institute at Virginia Mason (BRI) have found that proteins in the IL-6 signaling pathway may be leveraged as novel biomarkers of multiple sclerosis (MS) to gauge disease activity and as a target for new therapies. The research, which investigated how several components involved in immune response differ between MS patient and control samples, was conducted by a team of researchers at BRI led by Dr. Jane Buckner in collaboration with Dr. Mariko Kita at Virginia Mason Medical Center and was published today in Science Translational Medicine.</description>
	  <link>http://medicalxpress.com/news/2013-01-biomarker-potential-therapy-multiple-sclerosis.html</link>
	 <category>Immunology</category>
	 <pubDate>Wed, 30 Jan 2013 14:00:09 EST</pubDate>
	 <guid isPermaLink="false">news278766505</guid>
	 
</item>
<item>
     <title>New insights into how immune system fights atherosclerosis</title>
   	 <description>A study led by Columbia University Medical Center (CUMC) researchers has found that an important branch of the immune system, in reaction to the development of atherosclerotic lesions, mounts a surprisingly robust anti-inflammatory T cell response that helps prevent the disease from progressing. The findings may help inform the design of anti-atherosclerosis vaccines and other therapies that can take advantage of this aspect of the immune system. The study was published today in the online edition of the Journal of Clinical Investigation.</description>
	  <link>http://medicalxpress.com/news/2012-12-insights-immune-atherosclerosis.html</link>
	 <category>Immunology</category>
	 <pubDate>Fri, 21 Dec 2012 14:38:28 EST</pubDate>
	 <guid isPermaLink="false">news275323100</guid>
	 
</item>
<item>
     <title>Researchers say effective immunotherapy for melanoma hinges on blocking suppressive factors</title>
   	 <description>(Medical Xpress)—Researchers at the Moffitt Cancer Center have found that delayed tumor growth and enhanced survival of mice bearing melanoma were possible by blocking the reconstitution of myeloid-derived suppressor cells and Tregs (suppressors of anti-tumor activity) after total body irradiation had eliminated them. Blocking myeloid-derived suppressor cells and regulatory T-cell reconstitution improved adoptive T-cell therapy, an immunotherapy designed to suppress tumor activity.</description>
	  <link>http://medicalxpress.com/news/2012-12-effective-immunotherapy-melanoma-hinges-blocking.html</link>
	 <category>Immunology</category>
	 <pubDate>Tue, 11 Dec 2012 03:48:04 EST</pubDate>
	 <guid isPermaLink="false">news274420077</guid>
	 
</item>
<item>
     <title>One gene predicts rapid ALS progression 80 percent of the time</title>
   	 <description>(Medical Xpress)—The debilitating symptoms of amyotrophic lateral sclerosis, or ALS, appear to be increased by a lack of inflammation-reducing T cells, report scientists from the Methodist Neurological Institute in an upcoming print issue of The EMBO Molecular Medicine Journal.The researchers found that expression of the gene FoxP3—which helps control the production of anti-inflammatory T cells—was an indicator of disease progression in 80 percent of the patients they studied. Low FoxP3 levels were likely in patients whose ALS would develop rapidly, and vice versa.</description>
	  <link>http://medicalxpress.com/news/2012-12-gene-rapid-als-percent.html</link>
	 <category>Genetics</category>
	 <pubDate>Mon, 10 Dec 2012 08:14:23 EST</pubDate>
	 <guid isPermaLink="false">news274349583</guid>
	 
</item>
<item>
     <title>Are we closer to understanding the cause of deadly sepsis?</title>
   	 <description>Following an infection, dysregulation of the immune system can result in a systemic inflammatory response and an often fatal condition called severe sepsis or septic shock. Sepsis is not uncommon, yet its cause and underlying immune dysfunction remain poorly understood. Regulatory T cells (Tregs), a component of the immune system, now appear to have an important role in suppressing the immune response in advance of sepsis, and understanding this role may lead to new therapeutic strategies for improving patient outcomes, as described in a review article in Journal of Interferon &amp; Cytokine Research.</description>
	  <link>http://medicalxpress.com/news/2012-11-closer-deadly-sepsis.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 16 Nov 2012 12:56:11 EST</pubDate>
	 <guid isPermaLink="false">news272292918</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/areweclosert.jpg" width="90" height="90" />
</item>
<item>
     <title>Mouse model exposes a new type of T cell to target melanoma</title>
   	 <description>Cancers arise in the body all the time. Most are nipped in the bud by the immune response, not least by its T cells, which detect telltale molecular markers—or antigens—on cancer cells and destroy them before they grow into tumors. Cancer cells, for their part, evolve constantly to evade such assassination. Those that succeed become full-blown malignancies. Yet, given the right sort of help, the immune system can destroy even these entrenched tumors.</description>
	  <link>http://medicalxpress.com/news/2012-10-mouse-exposes-cell-melanoma.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 24 Oct 2012 12:00:01 EST</pubDate>
	 <guid isPermaLink="false">news270298157</guid>
	 
</item>
<item>
     <title>Vitamin D supplements may benefit lupus patients</title>
   	 <description>A new clinical study published in BioMedCentral's open access journal Arthritis Research and Therapy provides preliminary evidence that vitamin D supplementation could be considered an immunomodulatory agent for systemic lupus erythematosus (SLE), a debilitating autoimmune disease characterized not only by skin, joint, neurological and renal symptoms, but also by inflammation of tissue linings in the body.</description>
	  <link>http://medicalxpress.com/news/2012-10-vitamin-d-supplements-benefit-lupus.html</link>
	 <category>Arthritis &amp; Rheumatism</category>
	 <pubDate>Tue, 16 Oct 2012 20:00:01 EST</pubDate>
	 <guid isPermaLink="false">news269626017</guid>
	 
</item>
<item>
     <title>Immunologists find a molecule that puts the brakes on inflammation</title>
   	 <description>(Medical Xpress)—We couldn't live without our immune systems, always tuned to detect and eradicate invading pathogens and particles. But sometimes the immune response goes overboard, triggering autoimmune diseases like lupus, asthma or inflammatory bowel disease.</description>
	  <link>http://medicalxpress.com/news/2012-09-immunologists-molecule-inflammation.html</link>
	 <category>Immunology</category>
	 <pubDate>Fri, 28 Sep 2012 13:18:09 EST</pubDate>
	 <guid isPermaLink="false">news268057076</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/immunologist.jpg" width="90" height="90" />
</item>
<item>
     <title>Pregnancy generates maternal immune-suppressive cells that protect the fetus</title>
   	 <description>A new study published online in the journal Nature suggests it might be possible to develop vaccines to prevent premature birth and other pregnancy complications. If so, such vaccines would be the first intended to stimulate the subset of regulatory CD4 T cells that suppress the immune response.</description>
	  <link>http://medicalxpress.com/news/2012-09-pregnancy-maternal-immune-suppressive-cells-fetus.html</link>
	 <category>Immunology</category>
	 <pubDate>Wed, 26 Sep 2012 13:00:14 EST</pubDate>
	 <guid isPermaLink="false">news267876734</guid>
	 
</item>
<item>
     <title>Researchers find novel predictor for MDS progression risk</title>
   	 <description>Researchers at Moffitt Cancer Center and colleagues have discovered that changes in the physical characteristics of the effector memory regulatory T cell can predict the progression risk of myelodysplastic syndromes (MDS) to acute myeloid leukemia. The finding could improve prognostication for patients with MDS and better inform therapeutic decision making.</description>
	  <link>http://medicalxpress.com/news/2012-09-predictor-mds.html</link>
	 <category>Immunology</category>
	 <pubDate>Thu, 13 Sep 2012 04:51:23 EST</pubDate>
	 <guid isPermaLink="false">news266730411</guid>
	 
</item>
<item>
     <title>Team shows how childhood viral infection leads to increased risk for allergic asthma as adult</title>
   	 <description>(Medical Xpress)—Researchers in the Division of Pulmonary, Allergy and Critical Care Medicine at the University of Pittsburgh School of Medicine have shown in an animal model that a common childhood virus disables the normal immune tolerance transferred from the mother to child through breast milk, leading to increased susceptibility for allergic asthma later in life. Their findings were reported in the online version of Nature Medicine.</description>
	  <link>http://medicalxpress.com/news/2012-09-team-childhood-viral-infection-allergic.html</link>
	 <category>Immunology</category>
	 <pubDate>Wed, 12 Sep 2012 10:50:01 EST</pubDate>
	 <guid isPermaLink="false">news266662590</guid>
	 
</item>
<item>
     <title>Experimental combo treatment worsens type 1 diabetes</title>
   	 <description>(HealthDay)—A treatment regimen that is effective in preventing diabetes in a mouse model of the disease leads to worsening disease in patients with type 1 diabetes, according to a study published online June 20 in Diabetes.</description>
	  <link>http://medicalxpress.com/news/2012-08-experimental-combo-treatment-worsens-diabetes.html</link>
	 <category>Diabetes</category>
	 <pubDate>Fri, 24 Aug 2012 12:00:02 EST</pubDate>
	 <guid isPermaLink="false">news265027635</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/4-experimental.jpg" width="90" height="90" />
</item>
<item>
     <title>Researchers test drug combinations to prevent graft vs. host disease</title>
   	 <description>Researchers at Moffitt Cancer Center have conducted a clinical trial aimed at preventing graft vs. host disease (GVHD) in patients who have received hematopoietic (blood) cell transplants (HCT). The study, comparing the drug tacrolimus (TAC) in combination with either methotrexate (MTX ) or sirolimus (SIR), found that the sirolimus/tacrolimus (SIR/TAC) combination was more effective in preventing grades II-IV acute GVHD and moderate-severe chronic GVHD after allogeneic blood cell transplantation.</description>
	  <link>http://medicalxpress.com/news/2012-06-drug-combinations-graft-host-disease.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 26 Jun 2012 14:20:34 EST</pubDate>
	 <guid isPermaLink="false">news259939220</guid>
	 
</item>
<item>
     <title>FDA-approved drug daclizumab makes established cancer vaccine work better</title>
   	 <description>A team from the Perelman School of Medicine and the Abramson Family Cancer Research Institute at the University of Pennsylvania found that the FDA-approved drug daclizumab improved the survival of breast cancer patients taking a cancer vaccine by 30 percent, compared to those patients not taking daclizumab. This proof-of-concept study is published this week in Science Translational Medicine. Senior authors of the study are Robert H. Vonderheide, MD, DPhil, associate professor of Medicine, and James Riley, PhD, associate professor of Microbiology.</description>
	  <link>http://medicalxpress.com/news/2012-05-fda-approved-drug-daclizumab-cancer-vaccine.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 16 May 2012 14:00:03 EST</pubDate>
	 <guid isPermaLink="false">news256391812</guid>
	 
</item>
<item>
     <title>Regulatory immune cell diversity tempers autoimmunity in rheumatoid arthritis</title>
   	 <description>Untangling the root cause of rheumatoid arthritis has been a difficult task for immunologists, as decades of research has pointed to multiple culprits in our immune system, with contradictory lines of evidence. Now, researchers at The Wistar Institute announce that it takes a diverse array of regulatory T cells (a specialized subset of white blood cells) to prevent the immune system from generating the tissue-specific inflammation that is a hallmark of the disease. Regulatory T cell diversity, the researchers say, provides a cumulative protective effect against rheumatoid arthritis. When that diversity is not present, it allows the immune system to attack joints.</description>
	  <link>http://medicalxpress.com/news/2012-05-regulatory-immune-cell-diversity-tempers.html</link>
	 <category>Arthritis &amp; Rheumatism</category>
	 <pubDate>Tue, 08 May 2012 14:52:26 EST</pubDate>
	 <guid isPermaLink="false">news255707478</guid>
	 
</item>
<item>
     <title>Bone marrow transplantation assists in acceptance of donated organs</title>
   	 <description>In an organ transplant the recipient protects himself with an immune reaction against the alien organ. This reaction is counteracted long-term with the use of immunosuppressants. In future this medication might no longer be necessary. If bone marrow belonging to the donor is also transplanted, no immune reaction occurs. However, this is still associated with undesirable side effects. </description>
	  <link>http://medicalxpress.com/news/2012-04-bone-marrow-transplantation-donated.html</link>
	 <category>Surgery</category>
	 <pubDate>Tue, 03 Apr 2012 08:50:02 EST</pubDate>
	 <guid isPermaLink="false">news252660692</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/1-bonemarrowtr.jpg" width="90" height="90" />
</item>
<item>
     <title>Conditioning regimen beneficial for kidney recipients</title>
   	 <description>(HealthDay) -- Following a conditioning regimen of lymphoid irradiation (TLI) and antithymocyte globulin (ATG), the majority of HLA-matched kidney and hematopoietic cell transplant recipients can be withdrawn from immunosuppressive drugs, according to a small study published online March 8 in the American Journal of Transplantation.</description>
	  <link>http://medicalxpress.com/news/2012-03-conditioning-regimen-beneficial-kidney-recipients.html</link>
	 <category>Surgery</category>
	 <pubDate>Wed, 28 Mar 2012 18:08:10 EST</pubDate>
	 <guid isPermaLink="false">news252176882</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/conditioning.jpg" width="90" height="90" />
</item>
<item>
     <title>The balancing act between protection and inflammation in MS</title>
   	 <description>Scientists have discovered a molecular mechanism that could help explain how multiple sclerosis (MS) and other autoimmune diseases can be exacerbated by the onset of an infection.</description>
	  <link>http://medicalxpress.com/news/2012-02-inflammation-ms.html</link>
	 <category>Immunology</category>
	 <pubDate>Fri, 17 Feb 2012 11:16:23 EST</pubDate>
	 <guid isPermaLink="false">news248699773</guid>
	 
</item>
<item>
     <title>SIV infection may lead to increase in immune-suppressive Treg cells</title>
   	 <description>Tissue in monkeys infected with a close relative of HIV can ramp up production of a type of T cell that actually weakens the body's attack against the invading virus. The discovery, in lymph nodes draining the intestinal tract, could help explain how the HIV virus evades the body's immune defenses.</description>
	  <link>http://medicalxpress.com/news/2012-02-siv-infection-immune-suppressive-treg-cells.html</link>
	 <category>Immunology</category>
	 <pubDate>Tue, 14 Feb 2012 13:44:54 EST</pubDate>
	 <guid isPermaLink="false">news248449475</guid>
	 
</item>
<item>
     <title>Self-regulation of the immune system suppresses defense against cancer</title>
   	 <description>Regulatory T cells, which are part of the body's immune system, downregulate the activity of other immune cells, thus preventing the development of autoimmune diseases or allergies. Scientists at the German Cancer Research Center have now found the activation steps that are blocked by Tregs in immune cells. Since Tregs can also suppress the body's immune defense against cancer, the findings obtained by the DKFZ researchers are important for developing more efficient cancer treatments.</description>
	  <link>http://medicalxpress.com/news/2011-12-self-regulation-immune-suppresses-defense-cancer.html</link>
	 <category>Immunology</category>
	 <pubDate>Wed, 21 Dec 2011 09:45:25 EST</pubDate>
	 <guid isPermaLink="false">news243683081</guid>
	 
</item>
<item>
     <title>Peanut allergy turned off by tricking immune system</title>
   	 <description>Researchers have turned off a life-threatening allergic response to peanuts by tricking the immune system into thinking the nut proteins aren't a threat to the body, according to a new preclinical study from Northwestern Medicine. The peanut tolerance was achieved by attaching peanut proteins onto blood cells and reintroducing them to the body -- an approach that ultimately may be able to target more than one food allergy at a time.</description>
	  <link>http://medicalxpress.com/news/2011-10-peanut-allergy-immune.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 11 Oct 2011 11:49:10 EST</pubDate>
	 <guid isPermaLink="false">news237552538</guid>
	 
</item>
<item>
     <title>New insight into immune tolerance furthers understanding of autoimmune disease</title>
   	 <description>It is no easy task to preserve the delicate balance that allows us to maintain a strong immune system that can defend us from harmful pathogens, but that is sensitive enough to correctly identify and spare our own cells. Therefore, it is not surprising that the mechanisms that underlie immune activation and tolerance are not completely understood. Now, a new research study published by Cell Press in the journal Immunity and available online on September 15th provides intriguing insight into the complex immune regulatory mechanisms that underlie immune tolerance.</description>
	  <link>http://medicalxpress.com/news/2011-09-insight-immune-tolerance-furthers-autoimmune.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 15 Sep 2011 13:12:43 EST</pubDate>
	 <guid isPermaLink="false">news235308079</guid>
	 
</item>
<item>
     <title>Specialized regulatory T cell stifles antibody production centers</title>
   	 <description>A regulatory T cell that expresses three specific genes shuts down the mass production of antibodies launched by the immune system to attack invaders, a team led by scientists at The University of Texas MD Anderson Cancer Center reported online in the journal Nature Medicine.</description>
	  <link>http://medicalxpress.com/news/2011-07-specialized-regulatory-cell-stifles-antibody.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 25 Jul 2011 13:27:01 EST</pubDate>
	 <guid isPermaLink="false">news230819197</guid>
	 
</item>
<item>
     <title>Researchers may have discovered key to help women fight infections during pregnancy</title>
   	 <description>A normal but concerning consequence of pregnancy is the fact that pregnant women are more susceptible to infection.  University of Minnesota Medical School researchers have identified the underlying mechanisms for this physiologic immune suppression that may lead to new therapies to help ward off infections during pregnancy.</description>
	  <link>http://medicalxpress.com/news/2011-07-key-women-infections-pregnancy.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 21 Jul 2011 16:37:24 EST</pubDate>
	 <guid isPermaLink="false">news230485031</guid>
	 
</item>
<item>
     <title>Mechanism discovered for health benefit of green tea, new approach to autoimmune disease</title>
   	 <description>One of the beneficial compounds found in green tea has a powerful ability to increase the number of &quot;regulatory T cells&quot; that play a key role in immune function and suppression of autoimmune disease, according to new research in the Linus Pauling Institute at Oregon State University.</description>
	  <link>http://medicalxpress.com/news/2011-06-mechanism-health-benefit-green-tea.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 02 Jun 2011 14:00:49 EST</pubDate>
	 <guid isPermaLink="false">news226242011</guid>
	 
</item>
<item>
     <title>Is cleanliness wiping out our immune system?</title>
   	 <description>(Medical Xpress) -- Too much cleanliness has been linked to the alarming rise in auto-immune and allergic diseases in the Western world, says Professor Barbara Fazekas de St Groth from the Centenary Institute. But the answer to this dilemma could lie in our gut.</description>
	  <link>http://medicalxpress.com/news/2011-06-cleanliness-immune.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 02 Jun 2011 11:04:55 EST</pubDate>
	 <guid isPermaLink="false">news226231458</guid>
	 
</item>
<item>
     <title>Re-educating immune system: New cell therapy prevents organ rejection</title>
   	 <description>Researchers at King's College London have used cells found naturally in the body, to re-educate the immune system to prevent rejection of an organ transplant while remaining capable of fighting infections and cancer.</description>
	  <link>http://medicalxpress.com/news/2011-05-re-educating-immune-cell-therapy.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 18 May 2011 14:00:05 EST</pubDate>
	 <guid isPermaLink="false">news224942288</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/reeducatingi.jpg" width="90" height="90" />
</item>
<item>
     <title>Duplicating immunity boosting regulatory T-cells to unprecedented levels</title>
   	 <description>University of Minnesota Medical School researchers have discovered a method to quickly and exponentially grow regulatory T-cells &amp;#150; also known as &quot;suppressor cells.&quot; The new process enables replication of the cells by tens of millions in several weeks, a dramatic increase over previous duplication methods.  Historically, regulatory T-cells have been difficult to replicate.</description>
	  <link>http://medicalxpress.com/news/2011-05-duplicating-immunity-boosting-regulatory-t-cells.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 18 May 2011 14:00:01 EST</pubDate>
	 <guid isPermaLink="false">news224942164</guid>
	 
</item>


</channel>
</rss>
